Corporate Presentation May 2019 TSX: ALEF OTC: ALEAF Aleafia - PowerPoint PPT Presentation

Corporate Presentation May 2019 TSX: ALEF – OTC: ALEAF Aleafia Health Inc Confidential & Proprietary

Certain Statements herein relating to the Company constitute “forward looking statements” within the meaning of Certain statements herein relating to the Company constitute “forward looking statements”, within the meaning of applicable securities laws, including without limitation, statements regarding future estimates, business plans and/or objectives, sales programs, forecasts and projections, assumptions, expectations, and/or beliefs of future performance, are “forward-looking statements”. Such “forward-looking statements involve unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements. Forwardlooking statements include, but are not limited to, statements with respect to commercial operations, including production and/or sales of marijuana, quantities of future marijuana production, anticipated revenues in connection with such sales, the overall projected size of the market, completion and/or expansion of production facilities, and other Information that is based on forecasts of future results, estimates of production not yet determinable, and other key management assumptions. Actual results may differ materially from those expressed or implied by such forwardlooking statements and involve risk and uncertainties relating to the Company’s historical experience with regulatory changes, timeliness of government approvals for the granting of permits and licenses, changes in marijuana prices, actual operating performance of facilities , and other uninsured risks. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Contents are provided for general information purposes only and do not constitute an offer to sell or solicitation of an offer to buy any security in any jurisdiction 2 2 Confidential & Proprietary Confidential & Proprietary

3 138,000 kg TSX Venture $476 Top Performing Planned, Funded Production & Cultivation Facilities Company of the CultivationCapacity Year Million Market Capitalization 50,000 kg Planned, Funded 60,000 Extraction Capacity Medical Patients March 2019 TSX Up-listing 10 Million International Point Medical Expansion Cannabis Dataset Germany | Australia TSX: ALEF 3 Confidential & Proprietary

We Grow Together SCIENCE Data analytics and science-based medicine inform every decision, from strains to treatment. With continuous innovation, If it matters, measure it. research & development; SEEDING we are creating the We seed change by disrupting established industries. Cross- industry’s most reliable platform integration and cannabis innovation is how we do it. cannabis health & wellness WELLNESS consumer experience Specialized treatment programs, tailored cannabis education courses, and product innovation. We deliver wellness through diversification. 4 Confidential & Proprietary

Our Ecosystem 4 divisions 1 journey Cannabis Product FoliEdge Academy Health & Wellness Cannabis Consumer Innovation Service Clinics Experience We drive continuous innovation We leverage our global leading We educate, diagnose, treat and We are creating a unique, Continuous innovation, in cannabis cultivation, processing, medical patient experience to empower people to optimize global, multi-jurisdictional extraction and brand-building to create and share innovative health and wellness with compliant, ecommerce consumer powered by technology deliver science-based cannabis courseware for MDs, nurses, cannabinoid therapy. From pain marketplace. It is a scalable, to scale globally. health and wellness products for patients, families and employers. and anxiety, to paediatrics cannabis sales platform that will Aleafia Health consumers. Our responsibility is to lead and epilepsy and autism, we are there complement our current national share our expertise in cannabis for our patients - in hospitals, distribution network of provincial health and wellness. clinics and in their homes via government and retail channels. online telemedicine. We Grow Together 5 5 Confidential & Proprietary

Cannabis Product & Product & Brands Our Ecosystem Consumer Journey Integrating the Consumer Journey Distribution Seeding Learning & Customer Loyalty Sharing Research Securing Repeatable Doctor / Cannabis Product Journey High-Margin Patient Purchases Engagement Extraction Processing Information & Education Awareness Grow & Canada > Global Cannabis Consumer Journey Quality Control We Grow Together Cannabis Products & Marketplace Brands Purchase Cultivation 6 6 Confidential & Proprietary

Port Perry, ON Niagara, ON | Greenhouse Port Perry, ON 7,000 sq. ft. 160,000 sq. ft. Product Innovation Centre 1.1M sq. ft. 25,000 sq. ft. Indoor hydroponic cultivation facility Modern, automated moving container bench Prime agricultural farmland dedicated system to produce repeatable, standardized Currently extracting oils, to outdoor cultivation cannabis strains tinctures, sprays, gel caps $0.25 cost per gram target 50,000 kg Extraction Facility Complete. Phase II Expansion nearing Low-Cost Supply completion 38,000 kg annual Paris, ON Paris, ON Formulation and analytical laboratory built to low-cost supply 83-Acres 2,000kg GMP certifications Including largest ever LP-to-LP supply agreement Prime agricultural land – zoned for Multi-format production capacity industrial use. Internal best-use study within Product Innovation Centre currently underway. Port Perry (Indoor): Cultivation Niagara (Greenhouse): Cultivation Licence (expected Q2/19) Port Perry (Outdoor): Local Approval, Paris (Product Innovation): Cultivation, Medical & & Wholesale Licenses Cultivation License (expected early Q2/19) Non-medical Sales, and Processing Licences Continuous innovation, powered by in-house medical and product expertise 7 Confidential & Proprietary

160,000 sq. ft. Niagara Greenhouse Retrofitting & Construction Complete May 2019 8 Confidential & Proprietary

1.1 million sq. ft. 60,000 kg Cultivation Area Outdoor Grow Expansion Facility Build-out Complete 9 Confidential & Proprietary

50,000 kg Extraction Expansion Paris Phase II Product Call Centre Build- out Complete Construction Complete June 2019 Operational Ready in Mid- Q319 Phase II Expansion 10 10 Confidential & Proprietary

Cannabis Health & Wellness Capturing High Margins Within Industry leading Premium Pricing Industry Growth Segments With Brand Awareness & price per gram sold with Product Innovation premium products and strong health & 2025 wellness consumer brand awareness. Legal Cannabis Market Growth $146 Premium Medical Billion Total $ 14.52 Premium Non-Medical Medical $100 Aleafia Health average oil per gram Billion selling price: “One of the highest Today amongst peers.” -Leading bank analyst Mid-Point VS. $ 8.02 Value Non-Medical Wholesale Average price per gram sold in Canada -Statistics Canada 11 11 11 Confidential & Proprietary Confidential & Proprietary

Established Cannabis Proven Cannabis Brands Consumer Products Continuous product Innovation. Powered by research, experience, High Quality Premium Medical Cannabis Products consumer brand awareness Focused on High Margins and loyalty. Quality Grown Cannabis Strains Commercially Proven Non-Medical Cannabis Products (Adult-Use / Recreational) THC – CBD – Hybrids Sativa – Indica - Hybrids Market Leading Format Breadth Future CPG Brand Integrations Focused on Health Flower, Oil, Capsules, Sprays & Wellness Lifestyle Products 12 Confidential & Proprietary

Health & Wellness Services Canada’s largest clinic network • 900+ Canadian MDs and • Nurse Practitioners 60,000+ Patients • Listing with Canada’s largest pharmacy National, Global Distribution Platform Highly coveted supply agreement with Shoppers Drug Mart Canada Medical Provincial Distribution Canada Non-Medical Retailers Adult-Use / Recreational Global Expansion Global Export International Export 13 Confidential & Proprietary 1. Pending regulatory approval.

10 million point medical cannabis dataset Built for Businesses, Joint medical cannabis study to improve the Corporations, Colleges / management and treatment of insomnia and daytime sleepiness. Universities, Governments, ...driving new cannabis Associations, Regulatory Bodies, products and services Unions, Insurance, Benefits Continuous research powered by technology to seed wellness 45% Treatment Innovation Epileptic patients improved employment status Cannabinoid pharmacogenetics in medical Of patients who stopped using benzodiazepines following in first of its kind, 4000 patient study We Grow cannabis therapy study with medical cannabis treatment. Published in Journal of To be published in Journal of Drug Issues. Together G420 and AKESOgen. Study in progress. Cannabis & Cannabinoid Research . 14 Confidential & Proprietary